Seongnam-si, South Korea

Donghoon Yeom

USPTO Granted Patents = 5 

Average Co-Inventor Count = 18.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Daejeon, KR (2023)
  • Seongnam-si, KR (2024)

Company Filing History:


Years Active: 2023-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: **Innovator Donghoon Yeom: A Pioneer in Antibody Research**

Introduction

Donghoon Yeom, a noted inventor based in Seongnam-si, South Korea, has made significant contributions to the field of biotechnology with a focus on antibody development. With a total of four patents to his name, Yeom stands out as a key player in the innovation of therapeutic solutions targeting cancer.

Latest Patents

Yeom's latest patents showcase his dedication to advancing medical science. One of his significant patents is the **Anti-BCMA antibody and use thereof**, which includes an antibody or an antigen-binding fragment that specifically targets B-cell maturation antigen (BCMA). This innovation holds potential in effectively preventing or treating various cancers. Another notable patent is the **Anti-HER2/anti-4-1BB bispecific antibody and use thereof**, which pertains to an anti-4-1BB/anti-HER2 bispecific antibody. This invention also includes a pharmaceutical composition that contributes to methods for treating and preventing cancer.

Career Highlights

Donghoon Yeom has had a remarkable career, during which he has worked with prominent companies in the biotechnology sector. He has contributed his expertise to **Abl Bio Inc.** and **Yuhan Corporation**, both of which are known for their commitment to drug development and innovation in the healthcare industry.

Collaborations

Throughout his career, Yeom has collaborated with talented individuals in the field. Notable coworkers include Kyungjin Park and Hyejin Chung, with whom he has shared insights and worked on groundbreaking projects aimed at enhancing cancer treatment options.

Conclusion

Inventor Donghoon Yeom continues to pave the way in antibody research with his impressive patent portfolio and collaborative efforts. His cutting-edge innovations not only reflect his dedication to scientific advancement but also offer hope for effective cancer therapies. As the biotechnology landscape evolves, Yeom's contributions will undoubtedly play a significant role in shaping the future of cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…